Please use this identifier to cite or link to this item:
|Title:||Discovery of anxiolytic 2-ferrocenyl-1,3-thiazolidin-4-ones exerting GABA<inf>A</inf> receptor interaction via the benzodiazepine-binding site|
|Authors:||Pejović, Anka |
Bogdanovic, Goran A.
|Journal:||European Journal of Medicinal Chemistry|
|Abstract:||Herein, we report on the synthesis, spectral, crystallographic and electrochemical properties of a small library of N-substituted 2-ferrocenyl-1,3-thiazolidin-4-ones, designed as novel GABAA benzodiazepine-binding site ligands. The anxiolytic properties of the title compounds were evaluated in several different in vivo models, whereas the involvement of the GABAA receptor complex in the activity of the most potent compound, 2-ferrocenyl-3-(4-methoxyphenylethyl)-1,3-thiazolidin-4-one, was inferred from experiments with known GABAA-targeting agents. Ligand docking experiments revealed that the high, dose-dependent, anxiolytic activity of the new compounds might be due to their favorable interactions with the benzodiazepine-binding site of the GABAA receptor complex. The incorporation of the ferrocene core and fine tuning of the distance between the thiazolidinone core and an additional aromatic ring were judged to be crucial structural requirements for the observed anxiolytic effect. © 2014 Elsevier Masson SAS. All rights reserved.|
|Appears in Collections:||Faculty of Science, Kragujevac|
|[ Google Scholar ]|
Files in This Item:
|29.86 kB||Adobe PDF|
Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.